DSM Venturing

DSM Venturing is the corporate venture capital arm of Royal DSM, established in 2001 and headquartered in Heerlen, Netherlands. The firm focuses on investing in start-up companies that develop innovative products and services within the life sciences sector, which encompasses both animal and human health and nutrition. Over the years, DSM Venturing has invested in more than fifty emerging companies across the United States, Europe, and Israel. Its primary objective is to generate strategic options and enhance value for DSM and its broader ecosystem while achieving sustainable venture-grade investment returns.

Rob Beudeker

Investment Director

Scott Horner

Regional Managing Director North America

Greg McParland

Investment Director

Arpesh Mehta

Investment Director

Erik Rutten

Senior Investment Manager

Past deals in Beverages

Vivici

Series A in 2025
Vivici is a B2B company specializing in the production and supply of animal-free dairy proteins. Utilizing precision fermentation technology, they create nutritious and sustainable ingredients for food and beverage manufacturers, aiming to meet the increasing global demand for functional and environmentally friendly protein sources.

Vivici

Seed Round in 2023
Vivici is a B2B company specializing in the production and supply of animal-free dairy proteins. Utilizing precision fermentation technology, they create nutritious and sustainable ingredients for food and beverage manufacturers, aiming to meet the increasing global demand for functional and environmentally friendly protein sources.

Chinova Bioworks

Series A in 2022
Chinova Bioworks develops natural antimicrobial solutions based on a chitosan polymer derived from fungal-sourced technology, offering broad-spectrum protection to extend the shelf life of juices and other products. The company targets the beverage industry and broader markets, including foods, cosmetics, and personal care items, with a natural preservative designed to reduce spoilage and waste. Founded in 2016 and based in Fredericton, Canada.

Prenexus Health

Series B in 2021
Prenexus Health, Inc. is a manufacturer of natural prebiotic ingredients, specializing in the scientific research, development, and production of components for functional foods, beverages, and dietary supplements. Founded in 2015 and headquartered in Gilbert, Arizona, the company emphasizes digestive health and wellness through its innovative offerings, including XOS95, a highly purified prebiotic ingredient derived from high-fiber sugarcane. Prenexus Health is recognized as a global leader in the prebiotic sector, underpinned by extensive scientific and clinical research that supports its products' efficacy in enhancing digestive and microbiome health. The company serves clients in the fast-moving consumer goods sector, providing them with high-quality functional ingredients to improve their products.

Chinova Bioworks

Seed Round in 2019
Chinova Bioworks develops natural antimicrobial solutions based on a chitosan polymer derived from fungal-sourced technology, offering broad-spectrum protection to extend the shelf life of juices and other products. The company targets the beverage industry and broader markets, including foods, cosmetics, and personal care items, with a natural preservative designed to reduce spoilage and waste. Founded in 2016 and based in Fredericton, Canada.

Chinova Bioworks

Seed Round in 2018
Chinova Bioworks develops natural antimicrobial solutions based on a chitosan polymer derived from fungal-sourced technology, offering broad-spectrum protection to extend the shelf life of juices and other products. The company targets the beverage industry and broader markets, including foods, cosmetics, and personal care items, with a natural preservative designed to reduce spoilage and waste. Founded in 2016 and based in Fredericton, Canada.

Blue Prairie

Series A in 2016
Blue Prairie Brands LLC, based in Charlottesville, Virginia, specializes in the manufacture of inulin, a prebiotic ingredient known for its health benefits. The company produces soluble, indigestible fibers that enhance the nutritional content of various food products, beverages, and dietary supplements. Their flagship product is a gluten-free, non-GMO form of inulin, which supports digestive health when combined with probiotics. Additionally, Blue Prairie's innovative approach to production offers farmers a profitable rotation crop that aligns with their existing agricultural practices. By focusing on functional foods and dietary fiber, Blue Prairie Brands aims to improve the nutritional value of products in the market while promoting a healthy gut environment.

Isobionics

Venture Round in 2014
Isobionics is a biotechnology company specializing in the production of natural aroma ingredients for various markets, including food, beverage, flavor, and fragrance. Utilizing a proprietary fermentation process, Isobionics focuses on isoprenoid-based products, such as nootkatone and valencene, which are essential for creating high-quality flavors and fragrances. This innovative approach ensures that the ingredients are free from pesticides and seasonal variability, resulting in products that are both purer and more cost-effective. By delivering superior sensory experiences, Isobionics aims to meet the evolving needs of its customers across the food, beverage, oral care, and personal care industries.

Ganeden Biotech

Venture Round in 2007
Ganeden, Inc. is a biotechnology company based in Mayfield Heights, Ohio, that specializes in the manufacture and supply of probiotics and probiotic bacteria. Founded in 1997, the company focuses on developing advanced strains of probiotics that address limitations associated with traditional strains. Ganeden licenses its probiotic technology for use in a variety of applications, including functional food and beverages, dietary supplements, and personal care products. Key offerings include GanedenBacillus coagulans for food and beverage applications, Bonicel for anti-aging cosmetics, and Staimune, an immune health solution. The company has also established a strategic alliance with Sensus America. With a commitment to improving quality of life, Ganeden has successfully introduced a range of consumer products, selling nearly 200 million doses across over 40,000 retail outlets since its product launch in 2003. As of 2017, Ganeden operates as a subsidiary of Kerry Group plc.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.